Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical Trial
Clinical trial NCT06114225 · RECRUITING
Trial details
- NCT number
- NCT06114225
- Sponsor
- Ruijin Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-01
- Primary completion
- 2026-09-15
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.